Allergan laying out $90M+ for technology; Former Novartis U.K. site beng repurposed;

@FiercePharma: China's Jiangsu Hansoh plans $3B IPO to tap investor demand. FiercePharmaAsia story | Follow @FiercePharma

@CarlyHFierce: MannKind resolves to find new Afrezza marketing deal after Sanofi bails on partnership. FiercePharmaMarketing story | Follow @CarlyHFierce

> Allergan ($AGN), which has agreed to merge with Pfizer ($PFE), Thursday announced a deal to buy clinical-stage pharmaceutical company Anterios for $90 million and milestones to get its technology to deliver neurotoxins through the skin instead of through injection. Story

> West Sussex County Council will buy a 20-acre former Novartis ($NVS) site in Horsham and turn it into a campus in targeted at attracting life sciences companies. Report

> The American Cancer Society's annual report says the cancer death rate has dropped 23% since its peak in 1991, citing cancer immunotherapies like Opdivo and Keytruda as being promising for trimming the rate further. Report

Medical Device News

@FierceMedDev: KKR, Panasonic form newco Ascensia from Bayer Diabetes buy for $1.1B. Article | Follow @FierceMedDev

@EmilyWFierce: Drug price increases saw 'high water mark' year in 2015: Analysts. FiercePharma story | Follow @EmilyWFierce

@VarunSaxena2: NEA partner outlines challenging med tech VC landscape heading into 2016. Article | Follow @VarunSaxena2

> As NEA buys in, FDA calls for more innovative, affordable and effective hearing aids. Story

> J&J launches consumer health and wellness tech accelerator. Article

> Stealth machine learning startup raises $10M to develop a heart disease detection algorithm. More

Biotech News

@FierceBiotech: The scoop on every new drug approved in 2015. Feature | Follow @FierceBiotech

@JohnCFierce: It's all happening so fast--Alector raises $29M; NextCure launches with $67M; Pfizer leads $15M round for Cortexyme. More | Follow @JohnCFierce

@DamianFierce: Tweeting from HATEFUL 8 intermission & have to say it was jarring when Bruce Dern turned to the camera and said "The 8 of us sure are h8ful." | Follow @DamianFierce

> FDA gets into Rhythm with a 'breakthrough' title for orphan obesity drug. Story

> Allergan spends $90M to get its hands on a topical Botox project. Article

> Another Chinese biopharma lines up for a billion-dollar IPO. Item

CRO News

> PPD spins out its in-house biotech as sale rumors swirl. More

> Charles River spends $585M on WIL Research amid a buyout spree. Article

> UCB taps Evotec to pitch in on drug discovery. Story

> Altasciences rebrands its web of CROs in hopes of standing out. Report

Pharma Manufacturing News

> Baxter recalls more of its saline solutions after a bug was found. Report

> PharMEDium recalls blood pressure control drug due to discoloration/degradation. More

> French developer TxCell signs Belgian CMO for manufacturing deal. Story

> GSK Australia plant to begin using blow-fill-seal technology for vaccines. Item

> Hospira recalls magnesium sulfate injectable due to bad barcoding. Article

Pharma Asia News

> China's Simcere seeks return to public market with $1B HKEx IPO. Story

> Chinese New Year alert in Hong Kong after bird flu fatality. News

> Wanda plans $2.3B hospital investment in China. More

> Precision medicine plan in China may be announced in March. Report

> Takeda bets on microbiome targets in GI push with Enterome deal. Article